A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms

Clinical trial NCT07469891 · RECRUITING

Trial details

NCT number: NCT07469891
Sponsor: Prelude Therapeutics
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Polycythemia Vera (PV)Myelofibrosis (MF)Myeloproliferative Neoplasms (MPNs)Post-Polycythemia Vera Myelofibrosis Post-Essential Thrombocythemia Myelofibrosis Primary Myelofibrosis (PMF)

Start date: 2026-04-29
Primary completion: 2028-04-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.